Our previous work demonstrated that both KCa3.1 deletion and pharmacological inhibition reduce infarction and associated inflammatory responses in rodent models of ischemic stroke (Chen et al., 2016; Chen, Raman, Bodendiek, O'Donnell, & Wulff, 2011). Here, KCNN4 is linked to infarction.